Mycophenolate mofetil treatment of crescentic Henoch-Schönlein nephritis with IgA depositions

Scand J Urol Nephrol. 2008;42(2):178-80. doi: 10.1080/00365590701571514.

Abstract

Mycophenolate mofetil (MMF) is considered to be a promising therapeutic agent in primary glomerulonephritis but there are no data on the use of MMF in Henoch-Schönlein nephritis (HSN). Herein we report the first adult crescentic HSN patient in whom long-term complete remission was achieved after MMF therapy.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Biopsy
  • Disease Progression
  • Dose-Response Relationship, Drug
  • Female
  • Follow-Up Studies
  • Glomerulonephritis, IGA / drug therapy*
  • Glomerulonephritis, IGA / etiology
  • Glomerulonephritis, IGA / pathology
  • Humans
  • IgA Vasculitis / complications*
  • IgA Vasculitis / drug therapy
  • IgA Vasculitis / pathology
  • Immunosuppressive Agents / therapeutic use*
  • Kidney / pathology
  • Mycophenolic Acid / analogs & derivatives*
  • Mycophenolic Acid / therapeutic use
  • Prodrugs
  • Remission Induction / methods

Substances

  • Immunosuppressive Agents
  • Prodrugs
  • Mycophenolic Acid